Dienogest
This paper examines the efficacy and safety of dienogest, a progestin, in treating endometriosis-associated pain and lesions.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
The provided text does not include the paper’s study content, methods, results, or limitations; it only contains bibliographic and publication metadata for “Dienogest,” referencing a different article about diagnostic and therapeutic challenges of an oligosymptomatic vesicovaginal fistula in a complex endometriosis case. The “Reactions Weekly” citation indicates an item about dienogest, but without the underlying report details, no key findings can be accurately extracted. Because the full paper text is not present, specific conclusions and any explicit caveats stated by the authors cannot be summarized. This paper is centrally about endometriosis — it is included in the corpus as a dienogest-related item explicitly linked to an endometriosis case in the provided reference metadata.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Full text
502 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (1)
Source provenance
- openalex
- last seen: 2026-05-11T05:14:39.736072+00:00